CGCUS
After Hours
Back To Top
Last Updated: Oct 18, 2019 7:59 p.m. EDT Delayed quote

$20.25

0.04 0.20%
After Hours Volume: 37.9K
Agriculture 0.26%
Close Chg Chg %
$20.21 -0.55 -2.65% -0.55 -2.65%
Advanced Charting
  • $
  • %
  • Vol
Advanced Charting
107.3% vs Avg.
Volume: 5.2M 65 Day Avg. - 4.8M
Open: 20.87
Close: 20.21
19.61 Day Low/High 20.89
Day Range
17.89 52 Week Low/High 52.74

Your Watchlist

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Symbol
Company
Price
Chg/Chg %
No Items in Watchlist

There are currently no items in this Watchlist.

No Saved Watchlists

Create a list of the investments you want to track.

Uh oh

Something went wrong while loading Watchlist.

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Key Data

  • Open $20.87
  • Day Range 19.61 - 20.89
  • 52 Week Range 17.89 - 52.74
  • Market Cap $7.03B
  • Shares Outstanding n/a
  • Public Float 216.03M
  • Beta 1.03
  • Rev. per Employee $115.04K
  • P/E Ratio n/a
  • EPS $-4.95
  • Yield n/a
  • Dividend n/a
  • Ex-Dividend Date n/a
  • Short Interest 41.23M 09/30/19
  • % of Float Shorted 19.08%
  • Average Volume 4.81M

Performance

5 Day
  • 7.16%
1 Month
  • -21.05%
3 Month
  • -42.01%
YTD
  • -24.79%
1 Year
  • -51.42%

Recent News

  • MarketWatch
  • WSJ
Read full story

Cannabis stocks a sea of red as Green Organic’s financing woes weigh

Read full story

One year on, Canada’s legal cannabis market is down but not out

Read full story

What to do with a lump sum — invest now or wait for a pullback?

Read full story

Marijuana stocks, after declines of over 50%, are now only ludicrously overpriced

Canopy Growth's sale of AusCann stake shows a focus shift to core assets and profitability: Jefferies

Canopy Growth Corp.'s announcement earlier Tuesday that it has sold its 13.2% stake in Australian producer AusCann for proceeds of C$6 million ($4.8 million) is a sign that the Canadian company is starting to clear its balance sheet to focus more on core assets and attaining profitability, according to Jefferies. Analysts Owen Bennett and Ryan Tomkins said the increased focus ins welcome, but "we do wonder how much more cleaning up may have to come." The deal is immaterial to either cash of international positioning, they wrote in a note to clients. Canopy had C$2.3 billion of cash as of last quarter, and the Australian market is expected to be just 1% of the Canadian market next year. Canopy Chief Executive Mark Zekulin told the analysts at a July meeting that with all the M&A deals Canopy had conducted, the complexity in the business had become significant. "With Bruce Linton (the old CEO) often saying in interviews past a key part of his and Canopy's strategy was "go into a market, spend and dominate, and then do the same again", we wonder how many assets that have been acquired are indeed non core, especially as the cash Constellation gave Canopy often meant money was no object," they wrote, referring to the $4 billion investment made last year by the brewer of Corona beer. "Further, we wonder how much Canopy would get for these assets when it sells them?" They noted that Hiku, an all-stock deal that closed in September at C$600 million, has still produced minimal revenue. U.S.-listed shares of Canopy were up 6.6% Tuesday, but have fallen 25% in 2019, while the ETFMG Alternative Harvest ETF has fallen 22%, and the S&P 500 has gained about 20%.

Read full story

Hexo stock dives after downgrade, dragging cannabis sector lower

Canopy Growth sells its 13.2% stake in AusCann for C$6.3 million

Canopy Growth Corp. said Tuesday it has sold its 42 million-share stake in Australian cannabis company AusCann Group Holdings for 15 cents a share, raising total proceeds of C$6.3 million ($4.8 million). The trade was facilitated by Canaccord Australia. The stake was equal to 13.2% of AusCann. "The decision to divest our position in AusCann, which we obtained three years ago in exchange for support provided, will allow us to sharpen our focus on our wholly-owned operations in the market, while continuing to collaborate with our partners at AusCann," Canopy Chief Executive Mark Zekulin said in a statement. Shares rose 2.9% in premarket trade, but are down 30% in 2019, while the ETFMG Alternative Harvest ETF has fallen 26% and the S&P 500 has gained 18%.

Canopy Growth sells 42 million shares of AusCann for proceeds of C$6.3 mln

Canopy Growth Is Downgraded. There Is ‘Just Modest Upside.’

“We see a headwind for the Canadian cannabis market, ahead, based on sizable industry supply,” Seaport Global analyst Brett M. Hundley said.

Dow Futures Slip Amid Trade Deal Uncertainty

The Dow Jones Industrial Average looks set for a lower open Monday morning as questions abound about the trade agreement reached by the U.S. and China on Friday.

Canopy Growth, Hexo downgraded by Seaport; analysts recommend switch to US cannabis sector from Canadian

Seaport Global downgraded Canadian cannabis companies Hexo Corp. and Canopy Growth Corp. to neutral from buy on Monday, and reiterated neutral ratings on Aurora Cannabis Inc. and Tilray Inc. , leaving Aphria Inc. as the only buy-rated Canadian cannabis company in its coverage. "We see a headwind for the Canadian cannabis market, ahead, based on sizable industry supply that will aim to funnel into a limited retail store set," analysts Brett M. Hundley and Luke Perda wrote in a note to clients. "We expect pricing and margins to drop considerably." The analysts said their model, rating and price target for Green Organic Dutchman are under review, pending news on its efforts to get fresh financing. In the U.S. multi-state operator space, the analysts "see a completely different set of circumstances in place, and we would broadly recommend that investors rotate away from Canada and towards the US," they wrote. "We do not think that recent vape headlines will materially cut into forward MSO financials, and we see a number of opportunities for public MSOs on the horizon." Canopy shares were down 0.8% in premarket trade, while Hexo was down 4.7%. The ETFMG Alternative Harvest ETF was up 1.1%, but has fallen 25% in 2019, while the S&P 500 has gained 18%.

Canopy Growth downgraded to neutral vs. buy at Seaport

The Marijuana Stock Aphria Reports Its Earnings Tuesday. Here’s What to Watch.

The company will be the first to report results since last week’s selloff in pot stocks.

Read full story

Cannabis stocks pare early gains as profit doubts persist a day after major selloff

Read full story

Hexo revenue warning slams cannabis sector as stock tumbles 24%

The Marijuana Stock Shakeout Will Happen Over the Next Year, Analysts Say

Jefferies analysts Owen Bennett and Ryan Tomkins wrote that a number of negative headlines have impacted the sector in the past six months, as well few signs of profitability. Still, they feel greater risk and volatility is priced in for many stocks.

Read full story

Here’s your game plan after marijuana stocks got throttled Thursday

Canopy Growth downgraded by Jefferies as analysts slash price targets on sector by average 50%

Jefferies downgraded Canopy Growth Corp. on Friday and slashed its stock price targets for cannabis companies by an average of 50%, a day after a revenue warning from Hexo Corp. prompted a sharp selloff in the sector as investors moved to price in heightened risk. "With a number of negative headlines impacting the sector the last 6 months, and still with little sign of profitability, the sector has seen greater risk/volatility priced in," analysts Owen Bennett and Ryan Tomkins wrote in a note to clients. The analysts downgraded Canopy, the market leader, to hold from buy and cut their price target to C$25 ($18.8) from C$77. The analysts cut Hexo's stock price target to C$3.80 from C$7.70, cut Cronos to C$10 from C$15, lowered Aurora Cannabis price target to C$7 from C$14, cut Organigram to C8.20 from C10.50, cut Green Organic Dutchman to C$2.40 from C$6.50 and lowered Tilray's price target to $25 from $57. At the same time, they upgraded Hexo to hold from underperform and upgraded Organigram and Flowr Corp. to buy from hold. "The next 12 months price performance should see strong divergence between those who can execute/move to profit and the rest," the analysts wrote. Canopy shares fell 1.8% premarket. The stock has fallen 24% in 2019, while the ETFMG Alternative Harvest ETF has fallen 25% and the S&P 500 has gained 17%.

Canopy Growth stock price target cut to C$25 vs. C$77 at Jefferies

Canopy Growth downgraded to underperform from hold at Jefferies

No Headlines Available

Recent News

  • Other News
  • Press Releases

/R E P E A T -- Media Advisory - Hey, Brandon, thanks for all the love. Another Tokyo Smoke is rolling into town/

/R E P E A T -- Media Advisory - Hey, Brandon, thanks for all the love. Another Tokyo Smoke is rolling into town/

on CNW Group

Investors Beware: Tilray Stock Might Not Be Done Dropping

Investors Beware: Tilray Stock Might Not Be Done Dropping

on InvestorPlace.com

This Isn’t the Time to Buy Aurora Cannabis Stock

This Isn’t the Time to Buy Aurora Cannabis Stock

on InvestorPlace.com

Media Advisory - Hey, Brandon, thanks for all the love. Another Tokyo Smoke is rolling into town

Media Advisory - Hey, Brandon, thanks for all the love. Another Tokyo Smoke is rolling into town

on CNW Group

Canopy Growth Launches 27th Retail Banner Location: Welcome Tokyo Smoke - Brandon, Manitoba

Canopy Growth Launches 27th Retail Banner Location: Welcome Tokyo Smoke - Brandon, Manitoba

on CNW Group

Where Is the Rebound for Fallen Canopy Growth Stock?

Where Is the Rebound for Fallen Canopy Growth Stock?

on InvestorPlace.com

This Bad News Could Be the Best Thing Ever for CGC Stock

This Bad News Could Be the Best Thing Ever for CGC Stock

on InvestorPlace.com

Cannabis Stock Gainers And Losers From October 17, 2019

Cannabis Stock Gainers And Losers From October 17, 2019

on benzinga.com

Stay Far Away From Canopy Growth Stock … For Now

Stay Far Away From Canopy Growth Stock … For Now

on InvestorPlace.com

7 Reasons to Buy Canopy Growth Stock

7 Reasons to Buy Canopy Growth Stock

on InvestorPlace.com

Cannabis 2.0 May Reignite Rally in Aurora Cannabis Stock

Cannabis 2.0 May Reignite Rally in Aurora Cannabis Stock

on InvestorPlace.com

At This Point, Hexo Stock Could Really Use a Lifeline 

At This Point, Hexo Stock Could Really Use a Lifeline 

on InvestorPlace.com

Cronos Australia Offers Little Help to Cronos Group Stock

Cronos Australia Offers Little Help to Cronos Group Stock

on InvestorPlace.com

Load up on CGC Stock Before the Disappointment Starts to Fade

Load up on CGC Stock Before the Disappointment Starts to Fade

on InvestorPlace.com

One Year Later: How Every Major Cannabis Stock Has Performed Since Canadian Legalization

One Year Later: How Every Major Cannabis Stock Has Performed Since Canadian Legalization

on benzinga.com

Cannabis Stock Gainers And Losers From October 16, 2019

Cannabis Stock Gainers And Losers From October 16, 2019

on benzinga.com

Why Pot Stock Giant Canopy Growth (CGC) Will Continue to Struggle

Like the majority of cannabis stocks, Canopy Growth (CGC) has taken a big hit in 2019, as sentiment in the industry continues to ...[...]

on SmarterAnalyst

Houseplant Introduces New Product Formats And Increases Footprint Across Canada

Houseplant Introduces New Product Formats And Increases Footprint Across Canada

on CNW Group

Wait for the Dust to Settle Before Buying Canopy Growth Stock

Wait for the Dust to Settle Before Buying Canopy Growth Stock

on InvestorPlace.com

Canopy Growth Sells Stake In AusCann For $6.3M

Canopy Growth Sells Stake In AusCann For $6.3M

on benzinga.com

Investor Ideas Potcasts, Cannabis News and Stocks on the Move

Investor Ideas Potcasts, Cannabis News and Stocks on the Move

on Investorideas.com

Canopy Growth Launches 27th Retail Banner Location: Welcome Tokyo Smoke - Brandon, Manitoba

Canopy Growth Launches 27th Retail Banner Location: Welcome Tokyo Smoke - Brandon, Manitoba

on PR Newswire - PRF

Legal marijuana market 2019 - Global Overview by Size, Share, Growth, Trend and Forecast till 2026

Legal marijuana market 2019 - Global Overview by Size, Share, Growth, Trend and Forecast till 2026

on The Express Wire

PURA Positioned to Take Advantage of Cannabis 2.0 With NOUV Partnership

PURA Positioned to Take Advantage of Cannabis 2.0 With NOUV Partnership

on GlobeNewswire

PURA Positioned to Take Advantage of Cannabis 2.0 With NOUV Partnership

PURA Positioned to Take Advantage of Cannabis 2.0 With NOUV Partnership

on GlobeNewswire

Thinking about buying stock in Canopy Growth Corp, Cronos Group, Hepion Pharmaceuticals, Morgan Stanley, or Tilray?

Thinking about buying stock in Canopy Growth Corp, Cronos Group, Hepion Pharmaceuticals, Morgan Stanley, or Tilray?

on PR Newswire - PRF

These Top CBD Stocks Could be Major Beneficiaries of Cannabis 2.0

These Top CBD Stocks Could be Major Beneficiaries of Cannabis 2.0

on Financial News Media

These Top CBD Stocks Could be Major Beneficiaries of Cannabis 2.0

These Top CBD Stocks Could be Major Beneficiaries of Cannabis 2.0

on PR Newswire - PRF

Medical Marijuana Market to Set Phenomenal Growth in Key Regions by 2024

Medical Marijuana Market to Set Phenomenal Growth in Key Regions by 2024

on HTF Market Intelligence

CannabisNewsBreaks - Three Canadian Licensed Producers with Price Target Downgrades

CannabisNewsBreaks - Three Canadian Licensed Producers with Price Target Downgrades

on NetworkNewsWire

CBD Hemp Oil Market May Set New Growth Story | ENDOCA, CBD American Shaman, Gaia Botanicals, Medical Marijuana

CBD Hemp Oil Market May Set New Growth Story | ENDOCA, CBD American Shaman, Gaia Botanicals, Medical Marijuana

on HTF Market Intelligence

PURA - Puration Anticipate EVERx CBD Sports Water Sales Boost From Cannabis 2.0

PURA - Puration Anticipate EVERx CBD Sports Water Sales Boost From Cannabis 2.0

on GlobeNewswire

PURA - Puration Anticipate EVERx CBD Sports Water Sales Boost From Cannabis 2.0

PURA - Puration Anticipate EVERx CBD Sports Water Sales Boost From Cannabis 2.0

on GlobeNewswire

Canopy Growth completes previously announced acquisition of Beckley Canopy Therapeutics

Canopy Growth completes previously announced acquisition of Beckley Canopy Therapeutics

on PR Newswire - PRF

Investor Ideas Potcasts, Cannabis News and Stocks on the Move

Investor Ideas Potcasts, Cannabis News and Stocks on the Move

on Investorideas.com

Thinking about buying stock in Bristol-Myers Squibb, Canopy Growth Corp, Intel, Target, or Tilray?

Thinking about buying stock in Bristol-Myers Squibb, Canopy Growth Corp, Intel, Target, or Tilray?

on PR Newswire - PRF

Thinking about buying stock in Bristol-Myers Squibb, Canopy Growth Corp, Intel, Target, or Tilray?

Thinking about buying stock in Bristol-Myers Squibb, Canopy Growth Corp, Intel, Target, or Tilray?

on PR Newswire - PRF

Canopy Growth Announces New Chair of the Board of Directors

Canopy Growth Announces New Chair of the Board of Directors

on PR Newswire - PRF

Tweed | TerraCycle Celebrate Over One Million Pieces of Cannabis Packaging Collected for Recycling

Tweed | TerraCycle Celebrate Over One Million Pieces of Cannabis Packaging Collected for Recycling

on PR Newswire - PRF

PURA - Puration Prospects Rise With Cannabis Legalization 2.0

PURA - Puration Prospects Rise With Cannabis Legalization 2.0

on GlobeNewswire

Canopy Growth Corp.

Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada. (See Full Profile)

Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 23 Full Ratings

Competitors

Name Chg % Market Cap
Simply Good Foods Co. -1.06% $2.4B
Canopy Growth Corp. -2.71% $9.24B
S&W Seed Co. 0.84% $79.55M
Shineco Inc. -1.92% $11.66M
Competitor Data Provided ByCapital Cube Logo